Papers
Burnie JP, Carter TL, Hodgetts SJ, Matthews RC.
Fungal heat shock proteins in human disease.
FEMS Review (2006)
Matthews RC, Rigg G, Hodgetts S, Carter T, Chapman C, Gregory C, Illidge C, Burnie J.
Preclinical assessment of the efficacy of Mycograb, a human recombinant antibody against fungal HSP90.
Anitmicro Agents Chemother (2003); 47:2208-2216
Wigfield AM, Rigg GP, Kavari M, Webb AK, Matthews RC, Burnie JP.
Identification of an immunodominant drug efflux pump in Burkholderia cepacia.
J Antimicrob Chemother (2002); 49:619-624
Matthews RC, Burnie JP.
Recombinant antibodies: a natural partner in combinatorial antifungal therapy.
Vaccine (2005); 22:865-871
Burnie J, Matthews R.
Genetically recombinant antibodies: new therapeutics against candidiasis.
Expert Opin Biol Ther (2004); 4:233-241
Gregory C, Rigg GP, Illidge C, Matthews RC.
Quantification of Escherichia coli genomic DNA contamination in recombinant protein preparations by polymerase chain reaction and affinity-based collection.
Analytical Biochem (2001); 296:114-121
Nooney L, Matthews RC, Burnie J.
Evaluation of Mycograb®, Caspofungin and fluconazole in combination against Cryptococcus neoformans by checkerboard and time-kill methodologies.
Diag Micro Infect Dis (2005); 51:19-29
Burnie J, Carter T, Rigg G, Hodgetts S, Donohoe M, Matthews R.
Identification of ABC transporters in Vancomycin-resistant Enterococcus faecium as potential targets for antibody therapy.
FEMS Immunol Med Microbiol (2002); 33:179-189